Siemens Healthineers: quarterly results hailed
(CercleFinance.com) - Siemens Healthineers shares are up nearly 7% in Frankfurt this morning, hailed for the publication of adjusted EPS that is up 4% to E0.
51 for Q1 2024-25, ahead of analysts' expectations.
At E5.48bn, the German medical technology group's sales increased by 5.7% LFL, with growth driven by the Americas (+14%) and Asia Pacific excluding China (+8%).
With this growth in line with its forecasts, Siemens Healthineers confirms its targets for the current financial year, i.e. adjusted EPS of $2.35 to $2.50, and revenue growth of 5% to 6%.
Copyright (c) 2025 CercleFinance.com. All rights reserved.
51 for Q1 2024-25, ahead of analysts' expectations.
At E5.48bn, the German medical technology group's sales increased by 5.7% LFL, with growth driven by the Americas (+14%) and Asia Pacific excluding China (+8%).
With this growth in line with its forecasts, Siemens Healthineers confirms its targets for the current financial year, i.e. adjusted EPS of $2.35 to $2.50, and revenue growth of 5% to 6%.
Copyright (c) 2025 CercleFinance.com. All rights reserved.